Both in Pharmaceuticals
Cytokinetics vs Corcept Therapeutics
Over the past year CYTK returned −0.9% and CORT returned +10.4%; their daily moves had a correlation of 0.11.
CYTK −0.9% CORT +10.4%Growth of $1, one year, split-adjusted
| Metric | CYTK | CORT |
|---|---|---|
| Price | $62.99 | $81.12 |
| Market cap | $8.76B | $8.77B |
| Today | −0.51% | −5.62% |
| 1 month | −4.0% | −28.9% |
| 6 months | −0.6% | +57.8% |
| Year to date | −0.9% | +133.1% |
| 1 year | +1.6% | +12.6% |
| Revenue growth (YoY) | −57.1% | +31.7% |
| Gross margin | 90.5% | 98.4% |
| Net margin | −694.4% | 16.8% |
| P/E (TTM) | — | 160.9× |
| Price / sales | 129.4× | 10.6× |
| Net cash | $18.6M | $308.2M |
| Dividend yield | — | — |
| Volatility (60d) | 33.6% | 59.9% |
| Short % of float | 15.4% | 9.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).